Scholarly Index
Lahar Mehta
Amplyx Pharmaceuticals (United States); 1,550 total citations; 49 total publications; best world rank #384
Amplyx Pharmaceuticals (United States)
1,550Total citations
49Total publications
18H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Migraine and Headache Studies | 2021-2025 | 984 | US 235 | 72.96 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 739 | US 175 | 63.33 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 384 | US 95 | 55.66 |